What is Wound Systems?
Founded in 2005, Wound Systems operates at the intersection of clinical efficacy and patient-centric design. The company specializes in the distribution of the Dolphin Pressure Redistribution System, a sophisticated solution engineered to address the critical challenges of pressure ulcer treatment and prevention. Utilizing advanced fluid immersion technology, the firm's product portfolio—which includes the Dolphin Bed, Dolphin Operating Pad, and Wheel Chair Pad—provides a high-performance alternative to traditional support surfaces. By serving hospitals, extended care facilities, and home health organizations, Wound Systems has established itself as a vital partner in improving patient comfort and reducing the long-term costs associated with wound management.
How much funding has Wound Systems raised?
Wound Systems has raised a total of $58K across 1 funding round:
Debt
$58K
Debt (2021): $58K with participation from PPP
Key Investors in Wound Systems
PPP
Public-Private Partnership
What's next for Wound Systems?
With the recent infusion of capital, Wound Systems is strategically positioned to scale its operations and deepen its market penetration. The company is expected to focus on optimizing its supply chain and expanding its footprint within the institutional healthcare sector. As the demand for high-acuity wound care solutions continues to rise, the firm's commitment to evidence-based technology will likely serve as a primary driver for future growth. Management will likely prioritize the integration of its fluid immersion systems into broader clinical workflows, ensuring that healthcare providers can deliver superior outcomes while maintaining cost-effective care standards. This phase of development marks a pivotal transition from a specialized distributor to a more integrated player in the medical technology landscape.
See full Wound Systems company page
